Impact of Dysphagia Therapy in Parkinson’s Disease | ||
The Egyptian Journal of Hospital Medicine | ||
Article 14, Volume 69, Issue 4, October 2017, Pages 2258-2265 PDF (580.13 K) | ||
Document Type: Original Article | ||
DOI: 10.12816/0041527 | ||
Authors | ||
Faisal Ahmed M. Abu Shaigah1; Ahlammohammed Zabbani2; Alya Bakr A. Qadi3; Abdulrahman Mohammed M Aloufi4; Anmar Ahmed T Sultan5; Hussain Abdullah Aljuwayd6; Ahmed Ali H Ghawas7; Ahmed Mohammed Alawadh8; Fayezaemadaldeen Alam9; Mohammed Abdullah Alghamdi9; Reem Salem M Alenzi10; Fatimah Nader Al Jish11 | ||
1Dammam Medical Complex | ||
2Batterjee Medical College | ||
3Medical University of Lodz | ||
4King Khalid University | ||
5King Salman Hospital | ||
6Maastricht University, Netherlands | ||
7King Faisal University | ||
8Arabian Gulf University | ||
9King Abdulaziz University | ||
10Northern Border University | ||
11Qatief Central Hospital | ||
Abstract | ||
Background: Dysphagia is a common symptom in Parkinson's disease (PD) which indicates a difficulty in swallowing. It has been accompanied with poor quality of life (QoL), anxiety and depression. Aim of the Study: to assess the effects of dysphagia treatment in Parkinson’s disease. Materials and methods: Studies published up to July 2017 were found via a systematic comprehensive electronic database search using PubMed, Embase, and The Cochrane Library.Two reviewers independently assessed the studies using strict inclusion criteria. Results: Thirteen studies were enrolled in the present study and qualitatively analyzed using critical appraisal items. The review includes rehabilitative (exercises, electrical stimulation, bolus modification etc.) and pharmacologic treatment. Some well-designed controlled trials were included. However, none of the included studies fulfilled all criteria for external and internal validity. Thus, a meta-analysis was not carried out as most of the studies were not of sufficient quality. Conclusion: Rehabilitative treatment including Expiratory Muscle Strength Training (EMST) may be effective for dysphagia treatment solely coupled with dopaminergic therapy for PD. Recently developed other treatment methods such as implant-prosthodontic treatment and percutaneous injection of botulinum neurotoxin type A in the cricopharyngeal muscle on dysphagia is rather promising. Nevertheless, these preliminary results warrant further investigation concerning their clinical applicability, and further research should be conducted. | ||
Keywords | ||
Dysphagia; Swallowing disorder, Parkinson's disease, Therapy outcome | ||
Statistics Article View: 372 PDF Download: 558 |